http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9855222-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e6ae38703c8e143d7f17d96be5d1e90
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N31-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
filingDate 2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e391dd457e824a8231b2e1c28ad1e6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6359245f6fe61d8e9486396c3a1d76
publicationDate 2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9855222-B2
titleOfInvention Topical sanitizer that includes avenanthramides
abstract Topical sanitizers including alcohol-based gels, alcohol-based foams, alcohol-free foams, liquid soaps, alcohol-based wipes, and alcohol-based sprays include avenanthramides, which is an active component of oats that is beneficial to the skin. The concentration of avenanthramides can be substantially less when considering the use profile of the person using the sanitizers. Many healthcare workers sanitize their hands dozens of times a day. An effective dose of avenanthramides can be delivered to the skin even when the concentration in avenanthramides is relatively low due to the repeated application of the sanitizers during the day. In addition, a lower concentration of avenanthramides may be used to maintain healthy skin compared to a higher concentration that may be used to repair damaged skin. Minimum concentrations of avenanthramides in one or more topical sanitizers can be determined according to the use profile and the target amount of avenanthramides to deliver via the topical sanitizers.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017246095-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019352578-A1
priorityDate 2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008003273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002017493-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007059390-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010229281-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008234160-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7691436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6818232-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005037054-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5641494-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6004584-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4853978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6000061-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5014362-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015258003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5133090-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012294911-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6953582-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871233-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009191248-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7740622-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5830884-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8431142-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5691287-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7718240-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3942193-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3059241-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6416788-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013224273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008268077-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012102620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012171280-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007184186-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005081278-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8075965-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005076917-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012214878-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11046239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11645942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7107

Total number of triples: 82.